JSB Market Research: Myasthenia Gravis - Pipeline Review, H2 2014
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. See Full Report @ http://bit.ly/1BXnzhj
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
See Full Report @ http://bit.ly/1BXnzhj
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Product Description 41<br />
Mechanism of Action 41<br />
R&D Progress 41<br />
belimumab - Drug Profile 42<br />
Product Description 42<br />
Mechanism of Action 42<br />
R&D Progress 42<br />
BKT-130 - Drug Profile 45<br />
Product Description 45<br />
Mechanism of Action 45<br />
R&D Progress 45<br />
CK-2066260 - Drug Profile 46<br />
Product Description 46<br />
Mechanism of Action 46<br />
R&D Progress 46<br />
eculizumab - Drug Profile 47<br />
Product Description 47<br />
Mechanism of Action 47<br />
R&D Progress 47<br />
GL-2045 - Drug Profile 50<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language